Companies should prepare for increased regulatory scrutiny into healthcare transactions and increased emphasis on compliance programs.

The Federal Trade Commission (FTC), the Department of Justice (DOJ), and the Department of Health and Human Services (HHS) have announced a new public inquiry into the impact of corporate consolidation and practices in the healthcare sector, with a focus on what they are calling “corporate greed in healthcare.” We are tracking the inquiry and summarize here the key focus areas and outline steps companies can take to prepare themselves. We will be hosting a webcast on May 30, 2024, to share what we have learned so far and how we think this may play out over time.